Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Buzdar technique for staged removal of chest tubes lodged in the lung

Official title: The Buzdar Technique for Pulmonary Parenchymal Chest Tube Removal: Prospective Evaluation of a Novel Minimally Invasive Protocol

Run by University of Health Sciences Lahore · NCT07338019 · Data updated 2026-11-12

This will try the Buzdar technique — a gradual, staged removal — to take out chest tubes accidentally placed in the lung in stable adults to see if it can safely avoid major surgery.

More Chest Tube Removal trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment300 (estimated)
SponsorUniversity of Health Sciences Lahore
Academic / other
Locations1 site (Lahore, Punjab Province)
StatusRecruiting
StartedJuly 1, 2025
Main results expectedJune 30, 2027
Study endsSeptember 30, 2027
Registry record updatedJanuary 13, 2026
Trial IDNCT07338019 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (≥18) with imaging-confirmed intraparenchymal chest tube placement who are hemodynamically stable, do not have uncorrectable coagulopathy, and provide informed consent.

Probably not a fit

Patients with massive bleeding, a large bronchopleural fistula, unstable cardiopulmonary status, or uncorrectable coagulopathy are unlikely to benefit and require immediate operative management.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Chest tube insertion is common but can rarely injure lung tissue (pulmonary parenchymal chest tube, PPcT), causing bleeding, prolonged air leak, or infection. The Buzdar technique is a conservative, staged withdrawal method developed at the University of Health Sciences Lahore that gradually retracts the tube under clinical and imaging surveillance rather than proceeding immediately to thoracotomy or VATS. Eligible, hemodynamically stable adults with imaging-confirmed intraparenchymal tube placement will undergo stepwise removal with serial chest X-rays or CT and close monitoring for hemorrhage or air leak. Patients who deteriorate or meet exclusion criteria will be referred for immediate surgical management.

Why it matters

Potential benefit: If successful, this approach could let many patients avoid open or video-assisted surgery, reducing surgical risk, recovery time, and hospital resource use.

How similar studies have gone: Published literature to date reports only invasive surgical removals (thoracotomy or VATS) for PPcT, so this staged, minimally invasive technique is novel and largely untested in formal series.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients ≥18 years with confirmed intraparenchymal chest tube placement on chest CT or X-ray.
* Hemodynamically stable patients suitable for conservative staged removal.
* Patients providing informed consent.

Exclusion Criteria:

* Patients requiring immediate thoracotomy due to massive bleeding or large bronchopleural fistula.
* Patients with uncorrectable coagulopathy or unstable cardiopulmonary status.
* Patients refusing participation or lost to follow-up.

Where it's running

  • Services Hospital Lahore
    Lahore, Punjab Province, Pakistan
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.